CN103159823A - Folic-acid-modified peptide synthesis technique - Google Patents
Folic-acid-modified peptide synthesis technique Download PDFInfo
- Publication number
- CN103159823A CN103159823A CN2013101201766A CN201310120176A CN103159823A CN 103159823 A CN103159823 A CN 103159823A CN 2013101201766 A CN2013101201766 A CN 2013101201766A CN 201310120176 A CN201310120176 A CN 201310120176A CN 103159823 A CN103159823 A CN 103159823A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- dmf
- add
- resin
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a folic-acid-modified peptide synthesis technique, belonging to the field of medicine production. The synthesis technique comprises the following steps: 1) swelling with resin; 2) connecting a first amino acid; 3) deprotecting; 4) detecting; 5) washing; 6) condensing; 7) washing; 8) repeating the operations from the step 2) to the step 6) to sequentially connect amino acids in the sequence from right to left; 9) weighing 5 times of equivalent weight of folic acid, adding into a reaction tube; adding 5 times of equivalent weight of HBTU and 10 times of equivalent weight of DIEA (diisopropylethylamine), reacting for 30 minutes, removing the reaction solution, taking the resin, and carrying out ninhydrin detection; 10) cutting polypeptide from the resin for 120 minutes; 11) blow-drying, and washing; 12) purifying the polypeptide by HPLC (high performance liquid chromatography); 13) freeze-drying the purified solution to obtain the finished product; 14) identification: carrying out molecular weight identification of MS and purity identification by HPLC analysis; and 15) carrying out sealed packaging on the white powdered polypeptide, and storing at -20 DEG C. The invention enhances the success rate in the traditional technique; and since the connection of the polypeptide and folic acid is synchronously completed in the synthesis process, the labor cost is greatly lowered, and the efficiency is greatly enhanced.
Description
Technical field
The present invention relates to a kind of modified with folic acid peptide synthesis technique of medical production field.
Background technology
One of folic acid (Folic acid) vitamin B complex is equivalent to VitB11 (pteroylglutamic acid, PGA), is that Mitchell (H.K.Mitchell, 1941) extracts purifying from the leaf of spinach, so called after folic acid.The effect that promotes juvenile cell maturation in marrow is arranged, can cause megaloblastic anemia and leukopenia if the mankind lack folic acid, the pregnant woman is even more important.Peptide is that a-amino acid links together with peptide chain and the compound that forms, and it is also the intermediate product of proteolysis.The compound that is formed by two amino acid molecular dehydrating condensations is called dipeptides, in like manner analogizes tripeptides, tetrapeptide, pentapeptide etc. in addition.Usually the compound that is formed by 10 ~ 100 amino acid molecular dehydrating condensations is polypeptide.Their molecular weight is lower than 10,000Da(Dalton dalton), can see through semi-permeable membranes, do not precipitated by trichoroacetic acid(TCA) and ammonium sulfate.Also there is document that the peptide that is comprised of 2 ~ 10 amino acid is called oligopeptides (small-molecular peptides); The peptide of 10 ~ 50 amino acid compositions is called polypeptide; The peptide that is comprised of the amino acid more than 50 just is called protein.At present the research about the functional aspect of the combination of folic acid and polypeptide is a focus direction.But the method to the coupling of folic acid and polypeptide on market still is in the junior stage, and technique of the present invention is to have made optimization on forefathers' Research foundation.Can effectively improve the success ratio of coupling and reach yield, reducing synthetic cost.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art, optimize existing technical process, a kind of success ratio that can effectively improve coupling, and yield and reduce the modified with folic acid peptide new synthetic process of synthetic cost are provided.
The present invention is achieved by the following technical solutions:
A kind of modified with folic acid peptide synthesis technique, its synthesis technique step is as follows:
1) resin swelling
2-Chlorotrityl Chloride Resin resin is put into reaction tubes, add DCM (15ml/g), vibration 30min;
2) connect first amino acid
Fall solvent by husky core suction filtration, add the Fmoc-L-Pro-OH amino acid of 3 times of molar excess, then add the DIEA of 10 times of molar excess, add at last the DMF dissolving, vibration 30min;
3) deprotection
Remove DMF, add 20% piperidines DMF solution (15ml/g), 5min removes and adds 20% piperidines DMF solution (15ml/g), 15min again;
4) detect
Take out piperidine solution, get tens grainy resins, wash three times with ethanol, add triketohydrindene hydrate, KCN, each of phenol solution, 105 ℃-110 ℃ heating 5min deepen blue positive reaction;
5) wash
DMF (10ml/g) twice, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g);
6) condensation
Method a: three times of protected amino acids (FmocAAA-OH) are excessive, and three times of HBTU are excessive, all with DMF dissolving less as far as possible, add reaction tubes, add at once ten times of NMM excessive. reaction 30min;
7) wash DMF (10ml/g) once, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g); 8) repeat the operation of two to seven steps, from right to left the amino acid in catenation sequence successively;
9) 5 times of equivalent folic acid of weighing, join in reaction tubes, then adds the HBTU of 5 times of equivalents, the DIEA of 10 times of equivalents, and reaction 30min had both taken out reaction solution, got resin and carried out the triketohydrindene hydrate detection;
10) cut polypeptide from resin
Preparation cutting liquid (10/g) TFA 94.5%; Water 2.5%; EDT 2.5%; TIS 1%;
Clipping time: 120min;
11) dry up washing
Lysate is dried up with nitrogen as far as possible, wash six times with ether, then normal temperature volatilizes;
12) use the HPLC purified polypeptide;
13) at last with the solution freeze-drying after purifying, both obtained finished product;
14) identify
The finished product polypeptide that takes a morsel is respectively done the molecular weight identification of MS, and the Purity analyzed of HPLC;
15) with the polypeptide of white powder, pack-20 ℃ of preservations.
The present invention compared with prior art has following beneficial effect:
1. improve the success ratio of coupling and reach yield;
2. reduce synthetic cost.
Embodiment
Below in conjunction with embodiment, content of the present invention is described in further detail:
technique of the present invention is on the basis of the solid phase synthesis of polypeptide, utilize the synthetic advantage of Solid-phase Polypeptide, practical situation in conjunction with folic acid, and a kind of modified with folic acid peptide synthesis technique that proposes, at first be the polypeptide portion sequence of definite folic acid peptide that will synthesize, then the method according to solid phase synthesis is synthesized polypeptide, but first not cracking, only out get final product the end NH2 of polypeptide is exposed, then according to the actual molar equivalent of polypeptide, ratio with folic acid: polypeptide=5:1 drops into reaction with folic acid, then can detect very easily with triketohydrindene hydrate--whether NH2 exists can judge whether reaction is complete.This technique has improved the upper success ratio of traditional technology greatly, and also owing to being that polypeptide is connected connection and is synchronously completed in synthetic with folic acid, old friend's work cost has also reduced greatly, and efficient is greatly improved.
Be below synthesis material and related reagent:
1) protected amino acid raw material
Fmoc-AAA-OH, folic acid
2) condensation reagent
HBTU,DIEA
3) solvent
DMF, DCM, acetonitrile
4) resin
2-Chlorotrityl?Chloride?Resin
5) deprotecting regent
Piperidines
6) cutting reagent
TFA,TIS,EDT?,H2O
7) nitrogen
8) anhydrous diethyl ether
9) precise electronic balance
The synthesis technique step is as follows:
1) resin swelling
2-Chlorotrityl Chloride Resin resin is put into reaction tubes, add DCM (15ml/g), vibration 30min;
2) connect first amino acid
Fall solvent by husky core suction filtration, add the Fmoc-L-Pro-OH amino acid of 3 times of molar excess, then add the DIEA of 10 times of molar excess, add at last the DMF dissolving, vibration 30min;
3) deprotection
Remove DMF, add 20% piperidines DMF solution (15ml/g), 5min removes and adds 20% piperidines DMF solution (15ml/g), 15min again;
4) detect
Take out piperidine solution, get tens grainy resins, wash three times with ethanol, add triketohydrindene hydrate, KCN, each of phenol solution, 105 ℃-110 ℃ heating 5min deepen blue positive reaction;
5) wash
DMF (10ml/g) twice, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g)
6) condensation
Method a: three times of protected amino acids (FmocAAA-OH) are excessive, and three times of HBTU are excessive, all with DMF dissolving less as far as possible, add reaction tubes, add at once ten times of NMM excessive. reaction 30min;
7) wash
DMF (10ml/g) once, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g); 8) repeat the operation of two to seven steps, from right to left the amino acid in catenation sequence successively;
9) 5 times of equivalent folic acid of weighing, join in reaction tubes, then adds the HBTU of 5 times of equivalents, the DIEA of 10 times of equivalents, and reaction 30min had both taken out reaction solution, got resin and carried out the triketohydrindene hydrate detection;
10) cut polypeptide from resin
Preparation cutting liquid (10/g) TFA 94.5%; Water 2.5%; EDT 2.5%; TIS 1%;
Clipping time: 120min;
11) dry up washing
Lysate is dried up with nitrogen as far as possible, wash six times with ether, then normal temperature volatilizes;
12) use the HPLC purified polypeptide;
13) at last with the solution freeze-drying after purifying, both obtained finished product;
14) identify
The finished product polypeptide that takes a morsel is respectively done the molecular weight identification of MS, and the Purity analyzed of HPLC;
15) with the polypeptide of white powder, pack-20 ℃ of preservations.
Claims (1)
1. modified with folic acid peptide synthesis technique, it is characterized in that: the synthesis technique step is as follows:
1) resin swelling
2-Chlorotrityl Chloride Resin resin is put into reaction tubes, add DCM (15ml/g), vibration 30min;
2) connect first amino acid
Fall solvent by husky core suction filtration, add the Fmoc-L-Pro-OH amino acid of 3 times of molar excess, then add the DIEA of 10 times of molar excess, add at last the DMF dissolving, vibration 30min;
3) deprotection
Remove DMF, add 20% piperidines DMF solution (15ml/g), 5min removes and adds 20% piperidines DMF solution (15ml/g), 15min again;
4) detect
Take out piperidine solution, get tens grainy resins, wash three times with ethanol, add triketohydrindene hydrate, KCN, each of phenol solution, 105 ℃-110 ℃ heating 5min deepen blue positive reaction;
5) wash
DMF (10ml/g) twice, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g);
6) condensation
Method a: three times of protected amino acids (FmocAAA-OH) are excessive, and three times of HBTU are excessive, all with DMF dissolving less as far as possible, add reaction tubes, add at once ten times of NMM excessive. reaction 30min;
7) wash
DMF (10ml/g) once, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g); 8) repeat the operation of two to seven steps, from right to left the amino acid in catenation sequence successively;
9) 5 times of equivalent folic acid of weighing, join in reaction tubes, then adds the HBTU of 5 times of equivalents, the DIEA of 10 times of equivalents, and reaction 30min had both taken out reaction solution, got resin and carried out the triketohydrindene hydrate detection;
10) cut polypeptide from resin
Preparation cutting liquid (10/g) TFA 94.5%, water 2.5%, EDT 2.5%, and TIS 1%;
Clipping time: 120min;
11) dry up washing
Lysate is dried up with nitrogen as far as possible, wash six times with ether, then normal temperature volatilizes;
12) use the HPLC purified polypeptide;
13) at last with the solution freeze-drying after purifying, both obtained finished product;
14) identify
The finished product polypeptide that takes a morsel is respectively done the molecular weight identification of MS, and the Purity analyzed of HPLC;
15) with the polypeptide of white powder, pack-20 ℃ of preservations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101201766A CN103159823A (en) | 2013-04-09 | 2013-04-09 | Folic-acid-modified peptide synthesis technique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101201766A CN103159823A (en) | 2013-04-09 | 2013-04-09 | Folic-acid-modified peptide synthesis technique |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103159823A true CN103159823A (en) | 2013-06-19 |
Family
ID=48583387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101201766A Pending CN103159823A (en) | 2013-04-09 | 2013-04-09 | Folic-acid-modified peptide synthesis technique |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103159823A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111269291A (en) * | 2020-03-20 | 2020-06-12 | 三峡大学 | Oligopeptide synthesis and application of oligopeptide in medicine for inhibiting citrus saprogenicia citrobacter fingerlike penicillium |
CN113384715A (en) * | 2021-06-03 | 2021-09-14 | 上海市第十人民医院 | anti-VEGF (vascular endothelial growth factor) medicine containing cell penetrating peptide fusion protein as well as preparation method and application of anti-VEGF medicine |
CN114591391A (en) * | 2022-03-22 | 2022-06-07 | 湖北强耀生物科技有限公司 | Synthesis process of O-sugar peptide bond polypeptide |
CN114634425A (en) * | 2022-03-22 | 2022-06-17 | 湖北强耀生物科技有限公司 | Novel synthesis process of PSMA inhibitor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7038037B2 (en) * | 2002-06-20 | 2006-05-02 | Isis Pharmaceuticals, Inc. | Method for sequential support-bound synthesis of conjugated oligomeric compounds |
CN101224306A (en) * | 2008-02-20 | 2008-07-23 | 中山大学 | Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
CN102120756A (en) * | 2010-12-07 | 2011-07-13 | 南开大学 | Taxol-based small molecule hydrogel-nanosphere transmission system and preparation method thereof |
-
2013
- 2013-04-09 CN CN2013101201766A patent/CN103159823A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7038037B2 (en) * | 2002-06-20 | 2006-05-02 | Isis Pharmaceuticals, Inc. | Method for sequential support-bound synthesis of conjugated oligomeric compounds |
CN101224306A (en) * | 2008-02-20 | 2008-07-23 | 中山大学 | Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
CN102120756A (en) * | 2010-12-07 | 2011-07-13 | 南开大学 | Taxol-based small molecule hydrogel-nanosphere transmission system and preparation method thereof |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111269291A (en) * | 2020-03-20 | 2020-06-12 | 三峡大学 | Oligopeptide synthesis and application of oligopeptide in medicine for inhibiting citrus saprogenicia citrobacter fingerlike penicillium |
CN111269291B (en) * | 2020-03-20 | 2023-11-21 | 三峡大学 | Synthesis of oligopeptide and application of oligopeptide in medicines for inhibiting citrus saprophytic bacteria penicillium digitatum |
CN113384715A (en) * | 2021-06-03 | 2021-09-14 | 上海市第十人民医院 | anti-VEGF (vascular endothelial growth factor) medicine containing cell penetrating peptide fusion protein as well as preparation method and application of anti-VEGF medicine |
CN113384715B (en) * | 2021-06-03 | 2023-08-04 | 上海市第十人民医院 | anti-VEGF medicine containing cell penetrating peptide fusion protein, and preparation method and application thereof |
CN114591391A (en) * | 2022-03-22 | 2022-06-07 | 湖北强耀生物科技有限公司 | Synthesis process of O-sugar peptide bond polypeptide |
CN114634425A (en) * | 2022-03-22 | 2022-06-17 | 湖北强耀生物科技有限公司 | Novel synthesis process of PSMA inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103159823A (en) | Folic-acid-modified peptide synthesis technique | |
CN101693738B (en) | Method for synthesizing terlipressin by solid-phase oxidization and cyclization | |
CN103087152B (en) | Extraction process of oxytocin solution | |
CN102603869B (en) | Synthetic method of hexapeptide | |
CN102286589B (en) | The preparation method of turtle oligopeptide | |
CN107573408A (en) | A kind of synthetic method of high-purity Leuprorelin | |
CN104592362A (en) | Synthesis process of carbetocin | |
CN101838308B (en) | Solid-phase synthesis method for eptifibatide | |
CN105504012A (en) | Preparation method of polypeptide | |
CN104926920A (en) | Protein polypeptide drug N-terminal fixed-point polyethylene glycol modification method | |
CN105418736A (en) | Preparation method of terlipressin through combination of solid and liquid | |
CN103880945A (en) | Method for preparing high-purity thymalfasin | |
CN102286588B (en) | Method for preparing turtle peptide | |
CN103992390A (en) | Carbetocin synthesis method | |
CN109438551B (en) | Method for concentrating trace protein sample | |
CN107056894A (en) | A kind of method of fragment method synthesis in solid state ganirelix acetate | |
CN109053863A (en) | A kind of method of low cost preparation high-purity Linaclotide | |
CN105384799A (en) | Method for preparing sinapultide by combining solid phase and liquid phase | |
CN104277097B (en) | Method for preparing synthetic peptide antigen 2700 of swine O-type foot and mouth disease through solid-phase fragment process | |
CN103351426A (en) | Polypeptide synthesis method for octreotide acetate | |
CN110627875A (en) | Mitochondrion targeting membrane-penetrating cyclopeptide and preparation method and application thereof | |
CN109535162A (en) | A kind of preparation method of N- p-benzoyl glutamy folic acid | |
CN102212191B (en) | Amine-terminated polyether and continuous preparation method thereof | |
CN104017058A (en) | Method for preparing ganirelix acetate | |
CN113912673A (en) | Low-bitter ACE inhibitory peptide derived from sesame, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130619 |